These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 23828549

  • 1. Mucin phenotype expression of gastric neuroendocrine neoplasms: analysis of histopathology and carcinogenesis.
    Domori K, Nishikura K, Ajioka Y, Aoyagi Y.
    Gastric Cancer; 2014 Apr; 17(2):263-72. PubMed ID: 23828549
    [Abstract] [Full Text] [Related]

  • 2. Re-evaluation of phenotypic expression in undifferentiated-type early gastric adenocarcinomas using mucin core protein and CDX2.
    Ikarashi S, Nishikura K, Ajioka Y, Aoyagi Y.
    Gastric Cancer; 2013 Apr; 16(2):208-19. PubMed ID: 22829163
    [Abstract] [Full Text] [Related]

  • 3. [Clinicopathologic and immunohistochemical study on early gastric signet-ring cell carcinoma].
    Xiong ZF, Xiao H, Tan YS.
    Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):442-6. PubMed ID: 21055171
    [Abstract] [Full Text] [Related]

  • 4. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: II. Expression of MUC1, MUC2, MUC5AC, and MUC6 in normal mucosa and in 42 cases.
    Terada T.
    Int J Clin Exp Pathol; 2013 Jul; 6(4):613-21. PubMed ID: 23573307
    [Abstract] [Full Text] [Related]

  • 5. Hepatoid adenocarcinoma of the stomach: histogenesis and progression in association with intestinal phenotype.
    Kumashiro Y, Yao T, Aishima S, Hirahashi M, Nishiyama K, Yamada T, Takayanagi R, Tsuneyoshi M.
    Hum Pathol; 2007 Jun; 38(6):857-63. PubMed ID: 17320150
    [Abstract] [Full Text] [Related]

  • 6. The relationship among PDX1, CDX2, and mucin profiles in gastric carcinomas; correlations with clinicopathologic parameters.
    Oz Puyan F, Can N, Ozyilmaz F, Usta U, Sut N, Tastekin E, Altaner S.
    J Cancer Res Clin Oncol; 2011 Dec; 137(12):1749-62. PubMed ID: 21909647
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. CDX2 expression is increased in gastric cancers with less invasiveness and intestinal mucin phenotype.
    Ha Kim G, Am Song G, Youn Park D, Han Lee S, Hyun Lee D, Oh Kim T, Jae Jo H, Heo J, Hwan Kang D, Cho M.
    Scand J Gastroenterol; 2006 Aug; 41(8):880-6. PubMed ID: 16803685
    [Abstract] [Full Text] [Related]

  • 9. Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma.
    Silva EM, Begnami MD, Fregnani JH, Pelosof AG, Zitron C, Montagnini AL, Soares FA.
    Gastric Cancer; 2008 Aug; 11(3):149-59. PubMed ID: 18825309
    [Abstract] [Full Text] [Related]

  • 10. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
    Tang LH, Basturk O, Sue JJ, Klimstra DS.
    Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
    [Abstract] [Full Text] [Related]

  • 11. Gastroenteropancreatic High-Grade Neuroendocrine Neoplasms: Histology and Molecular Analysis, Two Sides of the Same Coin.
    Busico A, Maisonneuve P, Prinzi N, Pusceddu S, Centonze G, Garzone G, Pellegrinelli A, Giacomelli L, Mangogna A, Paolino C, Belfiore A, Kankava K, Perrone F, Tamborini E, Pruneri G, Fazio N, Milione M.
    Neuroendocrinology; 2020 Sep; 110(7-8):616-629. PubMed ID: 31557757
    [Abstract] [Full Text] [Related]

  • 12. CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer.
    Liu Q, Teh M, Ito K, Shah N, Ito Y, Yeoh KG.
    Mod Pathol; 2007 Dec; 20(12):1286-97. PubMed ID: 17906616
    [Abstract] [Full Text] [Related]

  • 13. Loss of MUC2 expression correlates with progression along the adenoma-carcinoma sequence pathway as well as de novo carcinogenesis in the colon.
    Mizoshita T, Tsukamoto T, Inada KI, Hirano N, Tajika M, Nakamura T, Ban H, Tatematsu M.
    Histol Histopathol; 2007 Mar; 22(3):251-60. PubMed ID: 17163399
    [Abstract] [Full Text] [Related]

  • 14. Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases.
    Murakami T, Yao T, Mitomi H, Morimoto T, Ueyama H, Matsumoto K, Saito T, Osada T, Nagahara A, Watanabe S.
    Gastric Cancer; 2016 Apr; 19(2):498-507. PubMed ID: 25893262
    [Abstract] [Full Text] [Related]

  • 15. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
    Nuñez-Valdovinos B, Carmona-Bayonas A, Jimenez-Fonseca P, Capdevila J, Castaño-Pascual Á, Benavent M, Pi Barrio JJ, Teule A, Alonso V, Custodio A, Marazuela M, Segura Á, Beguiristain A, Llanos M, Martinez Del Prado MP, Diaz-Perez JA, Castellano D, Sevilla I, Lopez C, Alonso T, Garcia-Carbonero R.
    Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
    [Abstract] [Full Text] [Related]

  • 16. Precursor-derived versus de-novo carcinogenesis depends on lineage-specific mucin phenotypes of intramucosal gland-forming gastric neoplasms.
    Nishimura R, Mukaisho K, Yamamoto H, Sonoda A, Andoh A, Fujiyama Y, Hattori T, Sugihara H.
    Histopathology; 2013 Nov; 63(5):616-29. PubMed ID: 24033890
    [Abstract] [Full Text] [Related]

  • 17. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma.
    Pinto-de-Sousa J, David L, Reis CA, Gomes R, Silva L, Pimenta A.
    Virchows Arch; 2002 Mar; 440(3):304-10. PubMed ID: 11889602
    [Abstract] [Full Text] [Related]

  • 18. Helicobacter pylori-negative Differentiated Adenocarcinoma of the Stomach.
    Nagaya T, Tanaka N, Iwaya Y, Jimbo Y, Tatai T, Ito T, Seki A, Suzawa K, Ochi Y, Hara E, Takata M, Otsuki T, Iwaya M, Hosaka N, Arakura N, Tanaka E, Hasebe O.
    Intern Med; 2015 Mar; 54(22):2857-62. PubMed ID: 26567998
    [Abstract] [Full Text] [Related]

  • 19. Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes.
    Tsukamoto T, Mizoshita T, Mihara M, Tanaka H, Takenaka Y, Yamamura Y, Nakamura S, Ushijima T, Tatematsu M.
    Histopathology; 2005 Jun; 46(6):649-58. PubMed ID: 15910596
    [Abstract] [Full Text] [Related]

  • 20. Quantitative analysis of the effect of Helicobacter pylori on the expressions of SOX2, CDX2, MUC2, MUC5AC, MUC6, TFF1, TFF2, and TFF3 mRNAs in human gastric carcinoma cells.
    Matsuda K, Yamauchi K, Matsumoto T, Sano K, Yamaoka Y, Ota H.
    Scand J Gastroenterol; 2008 Jan; 43(1):25-33. PubMed ID: 18938748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.